In pursuit of innovation to solve healthcare’s most important challenges
We are a healthcare company focused on saving lives and improving health by pioneering new technologies for early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges.
Our mission
Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care.
Leadership
Bob Ragusa
Chief Executive Officer
Joshua Ofman, MD, MSHS
President
Sir Harpal Kumar
President, Biopharma Business & Europe
Julie Currie
Chief People Officer
Aaron Freidin
Chief Financial Officer
Andy Partridge
Chief Commercial Officer
Satnam Alag, PhD
Senior Vice President, Software Engineering and Chief Security Officer
Paul Ciccolella
Senior Vice President, Global Technology and Operations
Amoolya Singh, PhD
Senior Vice President of Data Science and Chief Scientific Officer
Jeffrey Venstrom, MD
Senior Vice President of Medical Affairs and Chief Medical Officer
Abram Barth JD, MPH
General Counsel
Advisory Board
Otis Brawley, MD
Sidney Kimmel Comprehensive Cancer Center, School of Medicine Department of Epidemiology, Bloomberg School of Public Health Johns Hopkins University
Brian Druker, MD
Director, Knight Cancer Institute at Oregon Health & Science University JELD-WEN Chair of Leukemia Research
Dana Goldman, PhD
Interim Dean, USC Sol Price School of Public Policy Leonard D. Schaeffer Chair and Distinguished Professor of Pharmacy, Public Policy, and Economics, USC
Aashima Gupta, MS
Director, Global Healthcare Solutions, Google Cloud
Mark McClellan, MD, PhD
Robert J. Margolis Professor of Business, Medicine, and Policy Director of the Duke-Margolis Center for Health Policy at Duke University
Azra Raza, MD
Chan Soon-Shiong Professor of Medicine Director of the MDS Center at Columbia University, New York
Peter Sasieni, PhD
Academic Director of King's Clinical Trials Unit, Kings College London
Charles Swanton, FRCP BSc PhD
The Francis Crick Institute
Elias Zerhouni, MD
Professor Emeritus, Johns Hopkins University
